1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by mRNA Vaccines & Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global mRNA Vaccines & Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Standardization Of Cancer Treatment MRNA Vaccine
1.4.3 Individualized Cancer Treatment MRNA Vaccine
1.4.4 Infectious Disease Treatment MRNA Vaccine
1.4.5 Infection Prevention MRNA Vaccine
1.5 Market by Application
1.5.1 Global mRNA Vaccines & Therapeutics Market Share by Application: 2021-2026
1.5.2 Infectious Disease
1.5.3 Cancer
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global mRNA Vaccines & Therapeutics Market
1.8.1 Global mRNA Vaccines & Therapeutics Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global mRNA Vaccines & Therapeutics Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturers (2015-2020)
2.3 Global mRNA Vaccines & Therapeutics Average Price by Manufacturers (2015-2020)
2.4 Manufacturers mRNA Vaccines & Therapeutics Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Region (2015-2020)
3.2 Global mRNA Vaccines & Therapeutics Sales Revenue Market Share by Region (2015-2020)
3.3 North America mRNA Vaccines & Therapeutics Sales Volume
3.3.1 North America mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.3.2 North America mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia mRNA Vaccines & Therapeutics Sales Volume
3.4.1 East Asia mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.5.1 Europe mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.5.2 Europe mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.6.1 South Asia mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.7.1 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.8.1 Middle East mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.9.1 Africa mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.9.2 Africa mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.10.1 Oceania mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.11.1 South America mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.11.2 South America mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World mRNA Vaccines & Therapeutics Sales Volume (2015-2020)
3.12.1 Rest of the World mRNA Vaccines & Therapeutics Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World mRNA Vaccines & Therapeutics Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America mRNA Vaccines & Therapeutics Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia mRNA Vaccines & Therapeutics Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe mRNA Vaccines & Therapeutics Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia mRNA Vaccines & Therapeutics Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia mRNA Vaccines & Therapeutics Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East mRNA Vaccines & Therapeutics Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa mRNA Vaccines & Therapeutics Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania mRNA Vaccines & Therapeutics Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America mRNA Vaccines & Therapeutics Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World mRNA Vaccines & Therapeutics Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2015-2020)
14.2 Global mRNA Vaccines & Therapeutics Sales Revenue Market Share by Type (2015-2020)
14.3 Global mRNA Vaccines & Therapeutics Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global mRNA Vaccines & Therapeutics Consumption Volume by Application (2015-2020)
15.2 Global mRNA Vaccines & Therapeutics Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in mRNA Vaccines & Therapeutics Business
16.1 Moderna Therapeutics
16.1.1 Moderna Therapeutics Company Profile
16.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Specification
16.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 eTheRNA
16.2.1 eTheRNA Company Profile
16.2.2 eTheRNA mRNA Vaccines & Therapeutics Product Specification
16.2.3 eTheRNA mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 BioNTech
16.3.1 BioNTech Company Profile
16.3.2 BioNTech mRNA Vaccines & Therapeutics Product Specification
16.3.3 BioNTech mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 CureVac
16.4.1 CureVac Company Profile
16.4.2 CureVac mRNA Vaccines & Therapeutics Product Specification
16.4.3 CureVac mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 In-Cell-Art
16.5.1 In-Cell-Art Company Profile
16.5.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Specification
16.5.3 In-Cell-Art mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Translate Bio
16.6.1 Translate Bio Company Profile
16.6.2 Translate Bio mRNA Vaccines & Therapeutics Product Specification
16.6.3 Translate Bio mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Tiba Biotechnology
16.7.1 Tiba Biotechnology Company Profile
16.7.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Specification
16.7.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Argos Therapeutics
16.8.1 Argos Therapeutics Company Profile
16.8.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Specification
16.8.3 Argos Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Sangamo Therapeutics
16.9.1 Sangamo Therapeutics Company Profile
16.9.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Specification
16.9.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Ethris
16.10.1 Ethris Company Profile
16.10.2 Ethris mRNA Vaccines & Therapeutics Product Specification
16.10.3 Ethris mRNA Vaccines & Therapeutics Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 mRNA Vaccines & Therapeutics Manufacturing Cost Analysis
17.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
17.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 mRNA Vaccines & Therapeutics Distributors List
18.3 mRNA Vaccines & Therapeutics Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of mRNA Vaccines & Therapeutics (2021-2026)
20.2 Global Forecasted Revenue of mRNA Vaccines & Therapeutics (2021-2026)
20.3 Global Forecasted Price of mRNA Vaccines & Therapeutics (2015-2026)
20.4 Global Forecasted Production of mRNA Vaccines & Therapeutics by Region (2021-2026)
20.4.1 North America mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.2 East Asia mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.3 Europe mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.4 South Asia mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.6 Middle East mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.7 Africa mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.8 Oceania mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.9 South America mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World mRNA Vaccines & Therapeutics Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of mRNA Vaccines & Therapeutics by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.2 East Asia Market Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.3 Europe Market Forecasted Consumption of mRNA Vaccines & Therapeutics by Countriy
21.4 South Asia Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.5 Southeast Asia Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.6 Middle East Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.7 Africa Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.8 Oceania Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.9 South America Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
21.10 Rest of the world Forecasted Consumption of mRNA Vaccines & Therapeutics by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer